LGND

Ligand Pharmaceuticals Incorporated News Headlines

$56.92
*  
0.11
0.19%
Get LGND Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading LGND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Ligand Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for LGND
1/26/2015 4:30:22 PM - BNK Invest


Ligand Pharma Partner Retrophin Gets Orphan Drug Designation For Sparsentan
1/9/2015 10:23:00 AM - RTT News


Update: Ligand Partner Moves Closer To Delafloxacin Launch
1/8/2015 4:06:00 PM - Seeking Alpha


Spectrum Is An Interesting Biotechnology Investment
12/30/2014 1:01:00 PM - Seeking Alpha


Spectrum/Ligand Pharma Seek FDA Nod for CE-Melphalan - Analyst Blog
12/29/2014 5:00:00 PM - Zacks.com


Spectrum/Ligand Pharma Seek FDA Nod for CE-Melphalan - Analyst Blog
12/29/2014 5:00:00 AM - Investopedia


Update: Ligand Announces Key Regulatory Submissions
12/28/2014 9:36:00 AM - Seeking Alpha


Spectrum Pharma Submits NDA For CE-Melphalan
12/26/2014 8:00:00 AM - RTT News


Spectrum Pharma Submits NDA For CE-Melphalan - Quick Facts
12/26/2014 7:20:00 AM - RTT News


Update: Ligand Wins EU Approval For Duavive
12/21/2014 10:02:00 AM - Seeking Alpha


Ligand Pharmaceuticals: Investor Day Highlights The Big 6, All Undervalued Catalysts
11/24/2014 9:04:00 AM - Seeking Alpha


GSK Reports EU Submission For Severe Aplastic Anemia Indication For Revolade
11/12/2014 9:24:00 AM - RTT News


Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha


Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog
10/29/2014 1:00:00 PM - Zacks.com


Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success
10/29/2014 11:34:00 AM - Seeking Alpha


Update: Ligand Posts Consecutive Earnings Beat
10/28/2014 4:21:00 PM - Seeking Alpha


Sector Update: Health-Care Shares Flat Before Opening Bell
10/27/2014 7:49:25 AM - MT Newswires


Sector Update: Health Care
10/27/2014 7:45:32 AM - MT Newswires


Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
10/24/2014 4:20:00 PM - Zacks.com


Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog
10/24/2014 4:10:00 PM - Zacks.com


Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? - Analyst Blog
10/24/2014 4:00:00 PM - Zacks.com


Will Amgen (AMGN) Disappoint in the Q3 Earnings Season? - Analyst Blog
10/24/2014 3:45:00 PM - Zacks.com


Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss? - Analyst Blog
10/24/2014 3:11:00 PM - Zacks.com


Can Epizyme (EPZM) Surprise This Earnings Season? - Analyst Blog
10/24/2014 2:48:00 PM - Zacks.com


Ligand (LGND) Shares March Higher, Can It Continue? - Tale of the Tape
10/24/2014 8:27:05 AM - Zacks.com